The investigational dual GLP-1 and amylin receptor agonist Amycretin demonstrated significant weight loss—up to 24% with ...

The quest for weight loss has taken a dramatic turn. A wave of new-age solutions, from once-weekly injectables like Wegovy ...

Recent research from Coventry University casts doubt on cold plunges as a weight loss method, suggesting they may increase ...

May 12, 2025 – Turns out, two really is better than one – at least when it comes to weight loss drugs. In the first head-to-head trial of its kind, people with obesity who took tirzepatide ...

Middlesex County Popular ‘miracle’ weight loss drug is causing people to lose their vision, lawsuits claim Published: Jun. 19, 2025, 11:00 a.m.

GLP-1 agonists, medications commonly used for weight loss and type 2 diabetes, may also help reduce alcohol intake — an unexpected secondary benefit revealed in recent studies.

While weight loss is commonly advised to enhance cardiovascular and joint health in older adults, particularly those with ...

Reddit users often find support and shared experiences in online weight loss communities. New weight loss drugs like Ozempic ...

Amycretin helped patients lose over 24% of their weight, compared with an average of about 17% for Wegovy.

We have witnessed weight loss of 13–15% with the glucagon-like peptide-1 (GLP-1) receptor agonist semaglutide and up to 18–23% with the dual GLP-1/glucose-dependent insulinotropic polypeptide (GIP) ...

Novo Nordisk has submitted a new, higher dose of its obesity treatment, Wegovy, for approval to the European Medicines Agency ...

Nation and World Popular ‘miracle’ weight loss drug is causing people to lose their vision, lawsuits claim Published: Jun. 20, 2025, 11:05 a.m.